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Abstract: We redesigned residues on the surface of MICA, a protein that binds the homodimeric
immunoreceptor NKG2D, to increase binding affinity with a series of rational, incremental changes.
A fixed-backbone RosettaDesign protocol scored a set of initial mutations, which we tested by
surface plasmon resonance for thermodynamics and kinetics of NKG2D binding, both singly and in
combination. We combined the best four mutations at the surface with three affinity-enhancing
mutations below the binding interface found with a previous design strategy. After curating design
scores with three cross-validated tests, we found a linear relationship between free energy of
binding and design score, and to a lesser extent, enthalpy and design score. Multiple mutants
bound with substantial subadditivity, but in at least one case full additivity was observed when
combining distant mutations. Altogether, combining the best mutations from the two strategies
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into a septuple mutant enhanced affinity by 50-fold, to 50 nM, demonstrating a simple, effective
protocol for affinity enhancement.
Keywords: protein design; protein–protein interaction; immunoreceptors; additivity; free energy of
binding; thermodynamics and kinetics of binding; van’t Hoff enthalpy
Introduction
Improvement of protein–protein binding has utility
in applications ranging from in vitro assays to
in vivo therapies.1 Different strategies for enhancing
affinity incorporate combinatorial and/or computa-
tional design: combinatorial design tests large popu-
lations of randomized mutants in a process similar
to antibody affinity maturation, whereas computa-
tional or rational design calculates the biochemical
stability of protein conformations and amino acid
mutations using various scoring functions.2 Compu-
tational optimization of the chemical interactions in
proteins has successfully stabilized protein–protein
interfaces with final KD values ranging from micro-
molar to picomolar (Supporting Information Table
S1), although substantial challenges remain.3–5
Computational and combinatorial techniques can
work together, as when computational techniques
created a de novo 200 nM interface between influ-
enza hemagglutinin and a binding scaffold, and then
affinity maturation via combinatorial screening
produced three mutations that together brought the
affinity to 4 nM.6
Previously, we used the rational design algo-
rithm RosettaDesign to enhance the affinity of the
interface between the immunoproteins NKG2D and
MICA.7 This interaction acts as a dominant activat-
ing trigger for NK cells and is involved in several
pathologies.8 Our first design strategy targeted resi-
dues that do not directly contact NKG2D to alter the
stability of unbound MICA and affect NKG2D bind-
ing indirectly [Fig. 1(A)].7 Extrainterfacial changes
Figure 1. Locations redesigned with two strategies and measurement of binding thermodynamics and kinetics. (A) Targets
for design highlighted in the structure for the NKG2D-MICA complex (purple: NKG2D homodimer with core tyrosines shown
as sticks; yellow: MICA with redesigned residues shown as sticks; green: backbone of ‘‘disordered loop’’ region of MICA that
is not observed in the unbound MICA structure; orange/red: subinterfacial residues redesigned in first strategy, with stabilizing
residues combined in septuple mutant in red and labeled; light blue/dark blue: interfacial residues redesigned in second
strategy, with stabilizing residues combined in septuple mutant in dark blue and labeled). Figure was made using Pymol
http://www.pymol.org/. (B) SPR sensorgrams and residuals for injection of serial dilutions of NKG2D over a MICA-coupled
dextran surface (red: kinetic data collected; black: two-step model fit). (C) van’t Hoff plots of four single and three multiple
mutants for triplicate SPR data at nine temperatures, with KA values calculated from kinetic data and enthalpies of binding
calculated from linear slopes as described in Lengyel et al.
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in MICA that enhanced affinity for NKG2D were
predicted to destabilize the region underneath the
interface. A triple mutant was found with this strat-
egy that bound with 17-fold enhanced affinity.
Because none of these mutations directly con-
tacts NKG2D, we began a second round of rational
design in which MICA residues that directly contact
NKG2D were optimized with RosettaDesign to
enhance interfacial affinity, with the goal of com-
bining the mutations from the two strategies. Sin-
gle mutations predicted to enhance affinity were
expressed, purified, and tested experimentally.
Then mutations were combined iteratively with
other surface mutations, and with the most affinity-
enhancing mutations from our first subinterfacial
design strategy, to investigate the cumulative
effect of designed mutations at a protein–protein
interface.
Results and Discussion
RosettaDesign9 calculated an optimal amino acid
(selecting any amino acid except cysteine) 100 times
for each of the 22 MICA residues that contact
NKG2D in the MICA-NKG2D complex structure
(PDB ID: 1HYR).10 Each location was varied individ-
ually and all other residues were wild-type. For 11
locations, Rosetta either returned the wild-type resi-
due or a similar residue with insignificant predicted
stabilization (score >0.05), and the other 11 muta-
tions were investigated through experiment (bold
type in Supporting Information Table S2). Also, cal-
culations were done in which all MICA contact resi-
dues were allowed to vary at once. In the set of 100
such calculations, alterative stabilizing residues
were chosen by the algorithm more than 10% of the
time at six locations, which were added to the exper-
imental set as single mutants (normal type in Sup-
porting Information Table S2). These 17 single
mutants were produced by site-directed mutagene-
sis, expressed in Escherichia coli as inclusion bodies,
then refolded and purified by affinity and size-exclu-
sion chromatography. Each MICA mutant was
amine-coupled to a dextran surface on a gold chip
and its affinity for NKG2D measured by surface
plasmon resonance (SPR) [Fig. 1(B) and Supporting
Information Table S2]. For 11 mutants binding with
affinities similar to or stronger than wild-type, affin-
ities were determined at nine temperatures and
van’t Hoff plots constructed to calculate enthalpies
of binding [Fig. 1(C)]. Overall, this simple design
technique produced seven mutants that stabilized
the interaction with NKG2D by 0.5 kcal/mol or
more, with two stabilized by more than 1.0 kcal/mol
[Fig. 2(A)].
The best single mutations at the interface were
combined in 18 multiple-mutant MICA molecules,
which were analyzed for NKG2D binding by SPR
(Supporting Information Table S2). Most of the
single mutants stabilized the interaction with
NKG2D significantly, but combining mutations at
the interface resulted in eight MICA molecules sta-
bilized by 0.5 kcal/mol or more, four of which were
stabilized by more than 1.0 kcal/mol [Fig. 2(A)]. The
best multiple mutant from this step of the strategy
combined four of the best five single mutations,
increasing affinity by 1.74 kcal/mol about half of a
kcal/mol better than the best single mutant. The
H156A mutation was excluded from this combina-
tion after we observed that, despite its highly stabi-
lizing character in the context of wild-type MICA,
this mutation produced negative additivity when
combined with other mutations suggested by Roset-
taDesign in several multiple mutants [Fig. 2(B)].
H156A fails the first of our three design tests below
because Rosetta predicts an unrealistically large
upper-quintile stabilization to both bound and
unbound proteins. Inspection of the predicted struc-
tural model for H156A reveals that His156 forms
few specific interactions with NKG2D, and when it
is mutated to an alanine, a cavity is created in the
center of the disordered loop region of MICA that
may allow other mutations to shift in a manner not
captured by our fixed-backbone assumptions and/or
may increase stability and reduce flexibility of this
region in which flexibility is important to binding.7
Removing this mutation from the quintuple mutant
resulted in a 0.65 kcal/mol stabilization of interac-
tion with NKG2D.
In the final step of design, we combined the
best three subinterfacial mutations found previ-
ously7 with the four best interfacial mutations. The
resulting mutant bound NKG2D with a 50-fold
enhanced affinity, which is a 2.29 kcal/mol stabili-
zation relative to wild-type at 25C [Fig. 2(A)]. This
is similar to many computational results (Support-
ing Information Table S1), but it is also partially
subadditive by about a kcal/mol relative to the
added affinities of the triple and quadruple mutants
from the two design strategies [Fig. 2(B)]. The affin-
ity enhancement of the septuple mutant was con-
firmed with a previously developed size-exclusion
chromatography assay11 in which the mutant was
mixed with NKG2D and injected at a slow flow
rate. Under these conditions, the septuple mutant
eluted as a large peak (60 kDa), indicating that
the complex had persisted through the column, but
wild-type MICA eluted as a small peak (30kDa)
corresponding to unbound MICA monomer and
NKG2D dimer.
Design scores were calculated with RosettaDe-
sign for all expressed mutants to compare fixed-
backbone design calculations with experimental
results (Supporting Information Table S3). We
calibrated and cross-validated our NKG2D-MICA
calculations with 44 designed models recapitulating
published binding data for mutations at two
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antibody-antigen interfaces12 and a TCR-MHC inter-
face13, with affinities ranging from picomolar to
micromolar (Supporting Information Table S4).
Some design scores were apparent outliers by about
an order of magnitude, either from steric clashes
producing high repulsive energies or from unrealis-
tic stabilization calculations for particular interac-
tions. Three tests separated out the most extreme
upper-quintile calculated results:
1 Is the change the total design score undergoes
upon mutation within the 80th percentile of all
total scores? This was calculated as the absolute
value of any of the following relative to wild-type:
unbound ligand alone, bound protein–protein com-
plex, or the subtracted value of unbound-bound
[Eq. (1)]. For our set of NKG2D-MICA scores, this
corresponded to a value less than about 620
(Supporting Information Fig. S1). In terms of
Table S2, a passing score means the following
equation was true for the columns titled unbound,
bound, and bound-unbound (which is the unbound
value subtracted from the bound value to calculate
the change in energy upon binding):
jTotal design scorej < 20 (1)
2 Is the change the total design score undergoes on
mutation within the 80th percentile of all of Roset-
ta’s repulsive term (fa_rep) scores? For our set of
NKG2D-MICA scores, this also corresponded to a
value less than about 620. In terms of the col-
umns in Table S3, a passing score means the fol-
lowing equation was true for the columns
Drep_MICA (unbound), Drep_complex (bound),
and the two columns subtracted (as Drep_complex
 Drep_MICA):
jfa rep for mutant  fa rep for wild typej < 20 (2)
These two tests are similar to the criterion that
the design should not be predicted to significantly
Figure 2. Comparison of design scores (¼bound complex score–unbound MICA score relative to wild-type scores) to binding
thermodynamics of single and multiple mutants relative to wild-type MICA. (A) Experimentally determined free energies of
binding for all mutants tested arranged by number of mutations made (h: passed all three tests and sized and shaded by
relative design score, with best design score largest and colored black; X: failed one of the three design score tests). (B)
Additivity of mutants arranged with three sets of examples: negative additivity of H156A, subadditivity of D15N, and both
subadditivity and full additivity of N69W Bars shaded by number of mutations, from white:one mutation to black:seven
mutations; patterned bars:subinterfacial mutations from the first strategy. N ¼ D15N; T ¼ R38T; V ¼ D149V; D ¼ H158D; A ¼
H156A . Third section only: W ¼ N69W; E ¼ K152E; second D ¼ K154D. (C) Relationship between experimentally determined
free energy of binding and design score and (D) between enthalpy of binding and design score for mutants shown as black
boxes that pass the three tests (h: first-strategy N69W and second-strategy D15N mutants discussed in the text and closely
related combined mutants WED and NWED). R2 values for linear regression fits ¼ 0.61 and 0.40, respectively.
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destabilize the unbound molecules,14 also exclud-
ing unusually large predicted stabilization. Eight
designs of the 41 NKG2D-MICA mutants failed
one or both of the first two tests.
3 For the subtracted value of bound-unbound only:
does Rosetta’s side chain hydrogen bonding term
(hb_sc) stay the same or decrease? This threshold
was suggested by Sammond et al. to counteract
Rosetta’s reported tendency to replace a good
hydrogen bond with a less specific — for example,
hydrophobic — interaction in the bound com-
plex,14 and corresponds to the 80th percentile of
our set of hb_sc scores. We follow Sammond et al.
in using the subtracted value only (¼bound–
unbound), to the first decimal place, so that a
score of less than 0.05 is considered to stay the
same within error. In terms of the columns in Ta-
ble S3, the Dhb_sc_MICA value was subtracted
from the Dhb_sc_complex value so that a passing
score means the following equation was true:
½ðhb sc for mutant complex  hb sc wild-type complexÞ
 ðhb sc for mutant MICA  hb sc for
wild-type MICAÞ < 0:05 ð3Þ
Four more NKG2D-MICA designs failed this test.
Application of these thresholds to other interfa-
ces could use either the percentile or the raw score
depending on the number of scores in the design set.
Cross-validation with the experimental binding data
published for 44 mutations at the three other inter-
faces showed that the three tests marked out 20 of
Rosetta’s scores for these mutations as suspect, 17 of
which were successful applications of the tests
(either incorrect predictions by Rosetta or correct
predictions of destabilization; Supporting Informa-
tion Fig. S2). Interestingly, all three cases in which
the tests did not succeed—experimentally stabilizing
mutants correctly predicted by Rosetta yet incor-
rectly excluded by the tests—replaced glycine resi-
dues: two of these predicted the effects of mutating
glycines in the low-affinity MHC-TCR complex and
the third altered a glycine in an antibody CDR loop.
The MHC-TCR complex produced the most incorrect
predictions by Rosetta. For example, several TCR
mutants that replace a smaller residue with a larger
one fail tests 1 and 2 because of steric repulsion in
the complex (D26W and G28L) or in the unbound
TCR (G28I). In silico, the fixed-backbone model can-
not avoid these repulsions, but in vitro, these
mutants improve binding; in these cases, small back-
bone movements would minimize repulsion. Rosetta
scores for two other TCR mutations (G28M and
S100T) passed all three tests, yet incorrectly pre-
dicted destabilization of the complex; in these cases,
loop adjustments may allow stabilizing interactions
to form in the complex by the new side chain atoms
that cannot be reached in our fixed-backbone mod-
els. In general, Rosetta was able to more accurately
estimate quantitative effects of mutation for the
higher-affinity antibody-antigen complexes, but in
all three cases, the tests would have pre-filtered the
predictions so that a more experimentally amenable
set of stabilizing mutations remained.
After these tests were applied to curate the
Rosetta data for NKG2D-MICA, correlations were
observed for the remaining data, using the sub-
tracted design score suggested by Sammond et al.14
The best design score corresponds to the best experi-
mental result, which is the septuple mutant [Fig.
2(A)]. A linear relationship is observed between the
change in free energy of binding as determined by
SPR and the design score [Fig. 2(C)], and a similar
but more dispersed relationship is observed between
van’t Hoff enthalpy of binding and design score (note
that enthalpy measurements have a larger standard
error as well) [Fig. 2(D)]. Linear relationships within
some error have been observed between free energy
of binding and design score for various design meth-
ods.12,15,16 The linear relationship shown here
between enthalpy of binding and Rosetta’s design
score suggests that fixed-backbone Rosetta calcula-
tions better recapitulate characteristics associated
with enthalpy (e.g., charge-charge interactions, close
atom packing) than with entropy (e.g., flexibility).
Each design strategy produced one significantly
stabilizing (DDG<0.5 kcal/mol), peripherally
located mutation that Rosetta does not predict as
stabilizing: N69W for the subinterfacial strategy and
D15N for the interfacial strategy. These may pro-
mote NKG2D-MICA interface formation through
mechanisms more complex than optimizing direct
atomic contacts. For example, N69W is predicted to
destabilize the unbound MICA molecule, which bio-
physical tests have confirmed,7 and which is
reflected in the positive total design score for
unbound MICA relative to wild-type. In MHC mole-
cules, which are structurally homologous to MICA,
flexibility of the helices in the center of the binding
surface influences T-cell receptor binding.17,18 Such
movements in MICA would not be captured by fixed-
backbone calculations. D15N alters charge distribu-
tion on the outer edge of the interface, and is pre-
dicted to stabilize the MICA-NKG2D complex, but
also to stabilize the unbound MICA by the same
amount so that the subtracted design score predic-
tion is close to zero. Empirically, we found that this
mutation, alone and in combination with other
mutants, successfully stabilizes the interface.
Combining mutations at an interface can result
in different degrees of additivity,19,20,15 with subad-
ditivity observed for a T-cell receptor-MHC
interface21 and a single-chain Fv-PSA interface.22
Similarly, we repeatedly observed subadditivity and
negative additivity at this interface [Fig. 2(B)]. In a
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study of antibody affinity maturation, interface af-
finity was found to be inherently limited,23 so the
NKG2D-MICA interface architecture may impose a
structural limit here, particularly the requirement
that a homodimer engage a monomer with two sym-
metric half-sites on a flat surface. Also, mutations
located in independent modules distant from each
other combine additively,19,20 and the arrangement of
each NKG2D half-site as residues clustered around a
pair of tyrosines may cause each half-site to cooper-
ate as a single non-additive module. When the
NKG2D-MICA crystal structure was analyzed for
modules according to the technique of Reichmann
et al., each NKG2D half site consisted of a single co-
operative module (unpublished data). Distance from
the half-site cores may explain why the peripheral
mutation N69W provides a fully additive gain
observed in this study when combined with the sex-
tuple mutant to make the septuple mutant [Fig.
2(B)]. However, factors other than distance must
affect cooperativity, because two alterations in charge
distribution at the interface at opposite ends of the
NKG2D footprint, D15N and H158D, combine with
negative additivity in the ND mutant [Fig. 2(B)].
Conclusion
Here, we demonstrate a rational, iterative enhance-
ment of MICA that qualitatively changed NKG2D
affinity from weak (KD ¼ 2.5 lM) to moderately tight
(KD ¼ 51 nM) with seven mutations, engineering af-
finity past thresholds appropriate for applications
such as immunoprecipitation and vaccination.24,25
Different strategies of mutating residues that were at
and below the binding interface enhanced affinity,
although when combined, mutants often bound with
partial or negative additivity. Three tests identified 32
out of 85 design scores as incorrect or destabilizing,
with no wrongly identified scores for NKG2D-MICA,
and with three wrongly identified scores combined for
three other protein–protein interfaces. RosettaDesign
scores could be compared with experimentally deter-
mined free energies, showing that simple design
calculations with fixed backbone design can systemati-
cally enhance an existing protein interface.
Methods
Computational
RosettaDesign26 v2.1 was used to model side chain
mutations and calculate energies with the -fixbb
-repack_neighbors -soft_rep options selected.27,14
Structural coordinates from the PDB file (1HYR for
NKG2D-MICA) were relaxed, repacked, and remod-
eled with Rosetta to provide wild-type models, which
were then mutated, repacked, and evaluated. For
each mutant, Rosetta calculated a score 100 times
and an example with the lowest score from that set
was used. Most scores converged two to nine times
within the set of 100.
Experimental
Recombinant MICA and NKG2D proteins were pro-
duced and purified with affinity chromatography to
>95% purity and sized with size-exclusion chroma-
tography using methods identical to those previously
published in report of the first design strategy7 to
allow for comparison of results, including production
of proteins by undergraduates in a biochemistry
teaching laboratory.28 Plasmids for expression of sev-
eral mutant MICA molecules were constructed by
Genscript (Piscataway, NJ).
SPR assays were also consistent with earlier
work to allow for direct comparison of results, per-
formed on a BIAcore 3000 and fit with a two-step
model, which was supported by controls and biophysi-
cal tests.7 We confirmed in Lengyel et al. that relative
affinities on mutation for the MICA-NKG2D system
are similar for a two-step kinetic model and a simple
equilibrium model. (Recently, two-step modeling of
SPR kinetic data has been validated biophysically for
another protein–protein interface.29) The accuracy of
our independent measurements can be assessed by
comparing pairs of proteins with highly conservative
mutations that were made and evaluated by different
groups of students at different points in the project,
giving identical results within error: e.g., wild-type
vs. R64K (DDG ¼ 0.06 60.1 kcal/mol); and
R38T_H158D vs. R38T_H158DþY157F (DDG ¼
0.03 6 0.1 kcal/mol). Kinetic data were gathered at
five to nine temperatures and then combined into
van’t Hoff plots, with enthalpy calculated as reported
in Lengyel et al.
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